Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B
about
The Regulatory Networks That Control Clostridium difficile Toxin SynthesisAn Update on Clostridium difficile ToxinotypingDiversity and Evolution in the Genome of Clostridium difficileDissemination of Clostridium difficile in food and the environment: Significant sources of C. difficile community-acquired infection?Evaluation of the Cepheid Xpert C. difficile/Epi and meridian bioscience illumigene C. difficile assays for detecting Clostridium difficile ribotype 033 strains.Comparative genomic analysis of toxin-negative strains of Clostridium difficile from humans and animals with symptoms of gastrointestinal diseaseThe Point-of-Care Laboratory in Clinical Microbiology.Whole genome sequences of three Clade 3 Clostridium difficile strains carrying binary toxin genes in ChinaIs there a relationship between the presence of the binary toxin genes in Clostridium difficile strains and the severity of C. difficile infection (CDI)?Clostridial Binary Toxins: Basic Understandings that Include Cell Surface Binding and an Internal "Coup de Grâce".Prevalence of Clostridium difficile infection and colonization in a tertiary hospital and elderly community of North-Eastern Peninsular Malaysia.Genome characterization of a novel binary toxin-positive strain of Clostridium difficile and comparison with the epidemic 027 and 078 strains.Clostridioides difficile 630Δerm in silico and in vivo - quantitative growth and extensive polysaccharide secretion.Clostridium difficile infection diagnostics - evaluation of the C. DIFF Quik Chek Complete assay, a rapid enzyme immunoassay for detection of toxigenic C. difficile in clinical stool samples.Infection with Toxin A-Negative, Toxin B-Negative, Binary Toxin-Positive Clostridium difficile in a Young Patient with Ulcerative ColitisNMNI editorial report, 2016.Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027.The role of toxins in Clostridium difficile infection.Antibiotic Resistance and Toxin Production of Clostridium difficile Isolates from the Hospitalized Patients in a Large Hospital in Florida.The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model.Complete Genome Sequences of Four Toxigenic Clostridium difficile Clinical Isolates from Patients of the Lower Hudson Valley, New York, USA.Equivalent Performance of the Cobas® Cdiff Test for Use on the Cobas® Liat® System and the Cobas® 4800 System.New Insights into Clostridium difficile (CD) Infection in Latin America: Novel Description of Toxigenic Profiles of Diarrhea-Associated to CD in Bogotá, Colombia.Adaptive immune constraints on C. difficile vaccination.Clostridium difficile Toxoid Vaccine Candidate Confers Broad Protection against a Range of Prevalent Circulating Strains in a Nonclinical Setting.NMNI editorial report, 2017.Prevalence and Strain Characterization of in Representative Regions of Germany, Ghana, Tanzania and Indonesia - A Comparative Multi-Center Cross-Sectional Study
P2860
Q26748946-86E77DD8-F1B2-455A-B72F-F6BEE530F869Q26778130-1F1119D7-2BB4-456F-871D-323F8B49212DQ28084700-45769BCC-C717-4ABA-AD19-0F9C971BF5F8Q30241810-30F9AB8B-A62A-4990-8678-899D1D54BE6DQ35331079-71C1E6DA-7557-4127-AD77-6EAED70B03FBQ35955254-10BB82A3-9DAF-414F-8B93-5CEC12C9DFE3Q36886416-66AACE43-BEB1-45CB-AF73-68A029F9CBCFQ37681661-E130579E-5073-40AF-975B-9732B6D1A3B6Q38638507-3175DF40-37B9-4FB7-B5D0-24E0FC851539Q38845075-3E0EDDA1-2F0F-41C2-9B84-7EB079DCFB62Q40048152-457A385B-3F85-47F2-914C-94BEA0C69807Q40099512-9F000531-950A-44DF-ACF1-55D2A96776C6Q40256907-6E774A78-318A-4201-BC52-329464B5EEA0Q40533189-E36847E9-4EAC-43E8-B84E-9C7016AC0072Q41007833-33D4865F-469D-4DDB-8D18-980846A8E0F7Q42330285-25185F34-F69A-4D41-95CE-173171A52F78Q43167690-4BF51DF2-F002-4413-A88E-EEF3829227AFQ47734724-C929DE25-B80F-4802-8F08-A205AA5289C9Q49166361-D324E7BD-0FE7-402C-B7DB-156FE0B80D6CQ49282081-5A0BC020-0B4F-4633-9A6B-F09ABF11FFE2Q49480890-63B2EA38-3C18-4C53-963E-B8DCD0616712Q49638608-F9671246-B618-4A2C-A755-34F1AF185688Q50023348-76B97A94-AA75-4DD6-8CB0-04A901F8D546Q50130012-30E80221-4F07-4453-A3A9-6823DE9BF42CQ54239070-33C3E489-5F3B-4A6B-9D7F-A207614A8332Q55256670-A4F93D16-863C-4462-A36C-F774C14CAC3BQ58797243-8A91CF67-026C-404B-8660-204C04B46445
P2860
Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prevalence and pathogenicity o ...... do not produce toxins A and B
@ast
Prevalence and pathogenicity o ...... do not produce toxins A and B
@en
type
label
Prevalence and pathogenicity o ...... do not produce toxins A and B
@ast
Prevalence and pathogenicity o ...... do not produce toxins A and B
@en
prefLabel
Prevalence and pathogenicity o ...... do not produce toxins A and B
@ast
Prevalence and pathogenicity o ...... do not produce toxins A and B
@en
P2093
P2860
P1476
Prevalence and pathogenicity o ...... do not produce toxins A and B
@en
P2093
A De Chevigny
H De Montclos
H Jean-Pierre
H Marchandin
P2860
P356
10.1016/J.NMNI.2014.10.003
P577
2014-11-08T00:00:00Z